These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8872176)

  • 1. Binding of ALA-substituted analogs of HA306-320 to DR1101, DR1301, and DR0402 molecules: correlation of DR-peptide interactions with recognition by a single TCR.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Borras-Cuesta F; Sterkers G
    Hum Immunol; 1996 Sep; 50(1):61-9. PubMed ID: 8872176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sharing of four DR-beta sequence motifs between HLA-DRB1*1601 and DRB1*1101 correlates with frequent degenerate T-cell recognition of HA306-320 peptide complexed to these two molecules.
    Zeliszewski D; Dorval I; Golvano JJ; Prevost A; Borras-Cuesta F; Sterkers G
    Scand J Immunol; 1996 Feb; 43(2):146-54. PubMed ID: 8633194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for degenerate T-cell recognition of one peptide in the context of several DR molecules.
    Zeliszewski D; Gaudebout P; Golvano JJ; Dorval I; Prévost A; Borras-Cuesta F; Sterkers G
    Hum Immunol; 1994 Sep; 41(1):28-33. PubMed ID: 7836061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding analysis of 95 HIV gp120 peptides to HLA-DR1101 and -DR0401 evidenced many HLA-class II binding regions on gp120 and suggested several promiscuous regions.
    Gaudebout P; Zeliszewski D; Golvano JJ; Pignal C; Le Gac S; Borras-Cuesta F; Sterkers G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):91-101. PubMed ID: 9052717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an epitope of the human cytomegalovirus protein IE1 recognized by a CD4+ T cell clone.
    Gautier N; Chavant E; Prieur E; Monsarrat B; Mazarguil H; Davrinche C; Gairin JE; Davignon JL
    Eur J Immunol; 1996 May; 26(5):1110-7. PubMed ID: 8647175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides.
    Jurcevic S; Praud C; Coppin HL; Bertrand A; Ricard S; Thomsen M; Lakhdar-Ghazal F; De Preval C
    Immunology; 1996 Mar; 87(3):414-20. PubMed ID: 8778027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype.
    Geluk A; van Meijgaarden KE; Ottenhoff TH
    Immunology; 1997 Mar; 90(3):370-5. PubMed ID: 9155643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles.
    Valmori D; Sabbatini A; Lanzavecchia A; Corradin G; Matricardi PM
    J Immunol; 1994 Mar; 152(6):2921-9. PubMed ID: 7511633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of histidine beta81 of HLA-DR101 on peptide binding and presentation to T-cell receptor.
    Figueredo Dos Santos C; Tilkin-Mariame AF; De Préval C; Lakhdar-Ghazal F
    Hum Immunol; 2002 Jun; 63(6):459-66. PubMed ID: 12039521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
    Signorelli KL; Watts LM; Lambert LE
    Cell Immunol; 1995 May; 162(2):217-24. PubMed ID: 7743549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.
    Krieger JI; Karr RW; Grey HM; Yu WY; O'Sullivan D; Batovsky L; Zheng ZL; Colón SM; Gaeta FC; Sidney J
    J Immunol; 1991 Apr; 146(7):2331-40. PubMed ID: 1706393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
    Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
    Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.
    De Oliveira DB; Harfouch-Hammoud E; Otto H; Papandreou NA; Stern LJ; Cohen H; Boehm BO; Bach J; Caillat-Zucman S; Walk T; Jung G; Eliopoulos E; Papadopoulos GK; van Endert PM
    Mol Immunol; 2000 Oct; 37(14):813-25. PubMed ID: 11257303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein.
    Koehler NK; Yang CY; Varady J; Lu Y; Wu XW; Liu M; Yin D; Bartels M; Xu BY; Roller PP; Long YQ; Li P; Kattah M; Cohn ML; Moran K; Tilley E; Richert JR; Wang S
    J Med Chem; 2004 Oct; 47(21):4989-97. PubMed ID: 15456243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of binding capacities between HLA class II molecules and synthetic peptides HA307-319].
    Ikeda K; Katagiri M
    Hokkaido Igaku Zasshi; 1993 May; 68(3):318-24. PubMed ID: 8319931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces.
    Busch R; Strang G; Howland K; Rothbard JB
    Int Immunol; 1990; 2(5):443-51. PubMed ID: 1707655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.